Skip to main content


The POC analyzers market was valued at $268.7 million in 2021. Nucleic acid amplification tests (NAATs) and PCR systems are frequently used to screen for cytomegalovirus (CMV), human papillomavirus (HPV), mycobacterium tuberculosis, chlamydia trachomatis, hepatitis, and human immunodeficiency virus (HIV).